Publicacións en colaboración con investigadores/as de Universitat de Barcelona (13)

2024

  1. Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein–Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 9, pp. 2454-2467.e8

  2. How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?

    Influenza and other Respiratory Viruses, Vol. 18, Núm. 6

  3. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023

    Nature Medicine, Vol. 30, Núm. 6, pp. 1559-1563

  4. Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction-Related Biomarkers in Food Protein-Induced Enterocolitis Syndrome

    Clinical and Experimental Allergy

2023

  1. A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study

    The Lancet. Digital health, Vol. 5, Núm. 11, pp. e774-e785

2022

  1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

    The Lancet, Vol. 399, Núm. 10340, pp. 2047-2064

  2. Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries

    Frontiers in Pediatrics, Vol. 10

  3. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

2021

  1. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

2020

  1. Meningococcal disease: Can we predict the unpredictable?

    Medicina Clinica, Vol. 154, Núm. 1, pp. 20-22

  2. Reply to “Diagnostic criteria sets sensitivity”

    Journal of Allergy and Clinical Immunology: In Practice

2018

  1. Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol

    BMJ open, Vol. 8, Núm. 7, pp. e021032

2017

  1. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain

    BMC Infectious Diseases, Vol. 17, Núm. 1